Free Newsletter
Collins: Universal flu vax will be achieved in 5 years
Expect a universal flu vaccine within 5 years. That's according to NIH chief Francis Collins, who told USA Today that a long-term jab could replace the annual seasonal flu innoculations in that timeframe.
The achievement "seemed completely out of reach only a few years ago," Collins said to USA Today. But research has found consistencies in the viral coat that could help target all strains. The National Institute of Allergy and Infectious Diseases director Anthony Fauci noted last December that a portion of the hemagglutinin flu virus stem is relatively unchanged in many flu strains.
But some researchers believe more time will be needed to achieve the feat. "[It's] not a question of whether, but when," University of Michigan's Arnold Monto said to USA Today. "I think 5 years is a bit ambitious, given where we are now." Just last month, BiondVax announced it had completed the first Phase II universal flu vaccine trial in the world, with promising immunogenic results.
- check out the USA Today piece
- here's more from All Headline News
Related Articles:
Fauci outlines R&D challenges to universal flu vaccine
H1N1 provides new universal flu vax hope
Crucell and Scripps find antibody for universal flu vax
BiondVax releases promising Ph2 universal flu vax results
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: